A carregar...

ERRγ mediates Tamoxifen resistance in novel models of invasive lobular breast cancer

One-third of all ER+ breast tumors treated with endocrine therapy fail to respond, and the remainder are likely to relapse in the future. Almost all data on endocrine resistance has been obtained in models of invasive ductal carcinoma (IDC). However, invasive lobular carcinomas (ILC) comprise up to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Riggins, Rebecca B., Lan, Jennifer P-J., Zhu, Yuelin, Klimach, Uwe, Zwart, Alan, Cavalli, Luciane R., Haddad, Bassem R., Chen, Li, Gong, Ting, Xuan, Jianhua, Ethier, Stephen P., Clarke, Robert
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2701641/
https://ncbi.nlm.nih.gov/pubmed/18974135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-08-2669
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!